Qube Research & Technologies Ltd - ACUMEN PHARMACEUTICALS INC ownership

ACUMEN PHARMACEUTICALS INC's ticker is ABOS and the CUSIP is 00509G209. A total of 62 filers reported holding ACUMEN PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.98 and the average weighting 0.1%.

Quarter-by-quarter ownership
Qube Research & Technologies Ltd ownership history of ACUMEN PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$108,369
-39.9%
26,113
-41.2%
0.00%
-100.0%
Q1 2023$180,203
-37.5%
44,385
-16.8%
0.00%
-50.0%
Q4 2022$288,160
+71.5%
53,363
+219.3%
0.00%
+100.0%
Q3 2022$168,000
+60.0%
16,713
-24.9%
0.00%0.0%
Q2 2022$105,00022,2590.00%
Other shareholders
ACUMEN PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Sands Capital Ventures, LLC 3,417,075$14,180,8614.20%
Knollwood Investment Advisory, LLC 1,628,510$6,758,3173.16%
Altium Capital Management LP 650,000$2,697,5001.41%
RA Capital Management 14,932,063$61,968,0611.22%
GREAT POINT PARTNERS LLC 1,074,101$4,457,5190.81%
Boxer Capital, LLC 2,206,983$9,158,9790.49%
Deep Track Capital, LP 2,513,044$10,429,1330.40%
Parkman Healthcare Partners LLC 499,814$2,074,2280.38%
Rock Springs Capital Management LP 2,812,579$11,672,2030.31%
Ghost Tree Capital, LLC 150,000$622,5000.20%
View complete list of ACUMEN PHARMACEUTICALS INC shareholders